PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 64 | 1 | 11-16
Article title

Elevated expression of serine/threonine phosphatase type 5 correlates with malignant proliferation in human osteosarcoma

Content
Title variants
Languages of publication
EN
Abstracts
EN
Osteosarcoma is the most common primary malignant bone tumor in adolescents and young adults. However, the involvement of serine/threonine phosphatase type 5 (PP5) in osteosarcoma remains unclear. The aim of this study was to evaluate the functional role of PP5 in osteosarcoma cells. Firstly, we found that PP5 is widely expressed in several human osteosarcoma cell lines. Then we used lentivirus-delivered siRNA to silence PP5 expression in Saos-2 and U2OS cell lines. Knockdown of endogenous PP5 expression by shRNA-expressing lentivirus significantly decreased the viability and proliferation of the osteosarcoma cells. Moreover, FACS analysis showed that knockdown of PP5 expression induced a significant arrest in the G0/G1 phase of the cell cycle, which was associated with the inhibition of cell proliferation. Therefore, knockdown of PP5 is likely to provide a novel alternative to targeted therapy of osteosarcoma and deserves further investigation.
Year
Volume
64
Issue
1
Pages
11-16
Physical description
Dates
published
2017
received
2014-12-04
revised
2015-11-22
accepted
2016-05-05
(unknown)
2017-01-13
References
  • Atiye J, Wolf M, Kaur S, Monni O, Bohling T, Kivioja A, Tas E, Serra M, Tarkkanen M, Knuutila S (2005) Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 42: 158-163. doi: 10.1002/gcc.20120.
  • Bacci G, Briccoli A, Rocca M, Ferrari S, Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, Manfrini M, Galletti S (2003) Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol 14: 1126-1134.
  • Chinkers M (2001) Protein phosphatase 5 in signal transduction. Trends Endocrinol Metab 12: 28-32.
  • Ghobrial IM, McCormick DJ, Kaufmann SH, Leontovich AA, Loegering DA, Dai NT, Krajnik KL, Stenson MJ, Melhem MF, Novak AJ, Ansell SM, Witzig TE (2005) Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 105: 3722-3730. doi: 10.1182/blood-2004-10-3999.
  • Golden T, Aragon IV, Rutland B, Tucker JA, Shevde LA, Samant RS, Zhou G, Amable L, Skarra D, Honkanen RE (2008a) Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer. Biochim Biophys Acta 1782: 259-270. doi: 10.1016/j.bbadis.2008.01.004.
  • Golden T, Swingle M, Honkanen RE (2008b) The role of serine/threonine protein phosphatase type 5 (PP5) in the regulation of stress-induced signaling networks and cancer. Cancer Metastasis Rev 27: 169-178. doi: 10.1007/s10555-008-9125-z.
  • Gu J, Li K, Li M, Wu X, Zhang L, Ding Q, Wu W, Yang J, Mu J, Wen H, Ding Q, Lu J, Hao Y, Chen L, Zhang W, Li S, Liu Y (2013) A role for p21-activated kinase 7 in the development of gastric cancer. FEBS J 280: 46-55. doi: 10.1111/febs.12048.
  • Hinds TD Jr, Sanchez ER (2008) Protein phosphatase 5. Int J Biochem Cell Biol 40: 2358-2362. doi: 10.1016/j.biocel.2007.08.010.
  • Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H, Ichijo H (2001) Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J 20: 6028-6036. doi: 10.1093/emboj/20.21.6028.
  • Shirato H, Shima H, Nakagama H, Fukuda H, Watanabe Y, Ogawa K, Matsuda Y, Kikuchi K (2000) Expression in hepatomas and chromosomal localization of rat protein phosphatase 5 gene. Int J Oncol 17: 909-912.
  • Shweikeh F, Bukavina L, Saeed K, Sarkis R, Suneja A, Sweiss F, Drazin D (2014) Brain metastasis in bone and soft tissue cancers: a review of incidence, interventions, and outcomes. Sarcoma 2014: 475175. doi: 10.1155/2014/475175.
  • Sun W, Yao L, Jiang B, Shao H, Zhao Y, Wang Q (2012) A role for Cdkl1 in the development of gastric cancer. Acta Oncol 51: 790-796. doi: 10.3109/0284186X.2012.665611.
  • Tian J, Li X, Si M, Liu T, Li J (2014) CD271+ Osteosarcoma Cells Display Stem-Like Properties. PLoS One 9: e98549. doi: 10.1371/journal.pone.0098549.
  • Wechsler T, Chen BP, Harper R, Morotomi-Yano K, Huang BC, Meek K, Cleaver JE, Chen DJ, Wabl M (2004) DNA-PKcs function regulated specifically by protein phosphatase 5. Proc Natl Acad Sci U S A 101: 1247-1252. doi: 10.1073/pnas.0307765100.
  • Xu H, Liu X, Zhao J (2014) Down-regulation of miR-3928 promoted osteosarcoma growth. Cell Physiol Biochem 33: 1547-1556. doi: 10.1159/000358718.
  • Zhang J, Bao S, Furumai R, Kucera KS, Ali A, Dean NM, Wang XF (2005) Protein phosphatase 5 is required for ATR-mediated checkpoint activation. Mol Cell Biol 25: 9910-9919. doi: 10.1128/MCB.25.22.9910-9919.2005.
  • Zhou G, Golden T, Aragon IV, Honkanen RE (2004) Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. J Biol Chem 279: 46595-46605. doi: 10.1074/jbc.M408320200.
  • Zuo Z, Dean NM, Honkanen RE (1998) Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest. J Biol Chem 273: 12250-12258.
  • Zuo Z, Urban G, Scammell JG, Dean NM, McLean TK, Aragon I, Honkanen RE (1999) Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry 38: 8849-8857. doi: 10.1021/bi990842e.
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv64p11kz
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.